MedPath

SGL-TX-MR Study: The acute effect of SGLT2i on kidney transplant oxygen levels.

Phase 2
Active, not recruiting
Conditions
Kidney transplant recipients
Registration Number
2024-513765-40-00
Lead Sponsor
Odense University Hospital
Brief Summary

To evaluate the acute effect of SGLT2i on kidney allograft oxygen tension in cortex and medulla.

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing, recruitment ended
Sex
Not specified
Target Recruitment
8
Inclusion Criteria
  • Written informed consent must be provided before participation

  • Male or female patients ≥ 18 years of age

  • Non-diabetic kidney transplant recipients, > 6 months post-transplant

  • Stable eGFR> 20 ml/min (stable defined as eGFR 20 ml/min ± 5 ml/min variation in the last 3 months)

  • Tacrolimus(Adport) and Mycophenolatmofetile (Myfenax, cellcept) as part of immunosuppressive treatment

Exclusion Criteria
  • Diabetic kidney disease type 1 or 2 (World Health Organization (WHO) criteria)

  • Renal allograft failure (eGFR< 20 ml/min)

  • Alanine aminotransferase (ALAT) > 3 x upper normal limit or bilirubin > 2 x upper normal limit

  • Pregnancy or breastfeeding

  • Exclusion criteria for MRI o Claustrophobia/physical not able to lie in MR-scanner for 2 hours o MRI safety hazards such as cardiac pacemaker, implantable cardioverter defibrillator (ICD), non-MRI compatible implants and implanted devices, intraorbital or intracranial metallic foreign bodies.

  • Allergy towards SGLT2i or the content substance

  • Known intestinal bowel disease

  • Prednisone treatment

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
• Kidney allograft cortical and medullary oxygen tension, estimated by BOLD-MRI based renal T2* relaxation rate.

• Kidney allograft cortical and medullary oxygen tension, estimated by BOLD-MRI based renal T2* relaxation rate.

Secondary Outcome Measures
NameTimeMethod
• Renal cortical and medullary perfusion ml/100 g/min

• Renal cortical and medullary perfusion ml/100 g/min

• Renal artery blood flow ml/min

• Renal artery blood flow ml/min

• Blood glucose mmol/L

• Blood glucose mmol/L

• Systolic blood pressure (SysBP) and diastolic blood pressure (DiaBP) mmHg

• Systolic blood pressure (SysBP) and diastolic blood pressure (DiaBP) mmHg

• Heart rate (HR), beats min-1

• Heart rate (HR), beats min-1

Trial Locations

Locations (1)

Odense University Hospital

🇩🇰

Odense C, Denmark

Odense University Hospital
🇩🇰Odense C, Denmark
Lotte Borg Lange
Site contact
+4540863392
Lotte.Borg.Lange@rsyd.dk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.